The Future of
Targeted Delivery

We are a premier technology company that is developing a cell specific payload delivery solution with applications from monogenic diseases to oncology, neurodegenerative disease, metabolic disease and more.

Connect With Us

The CARGO System

CARGO is Carrigent’s patent-pending technology that offers increased loading capacity, cell-specific targeting and reduced systemic toxicity.

See Our Approach
DNA
Increased payload capacity
Target
Precision targeting to specific cell type
Growth
Best-in-class viral production yields
In CGT, delivery is the key.

What We Do

Carrigent's aim is to solve limitations associated with delivery platforms with the CARGO system. We can reduce cost, toxicity and immunogenicity issues while providing a broader array of payload and an increased capacity. CARGO is the next generation advanced therapy delivery platform.

Get to Know Us

Ready to Empower Your Research?

Connect With Us
Carrigent